You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

Properties

Applications

Our Abpromise guarantee covers the use of ab57080 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB
  • Application notesWB: Use at a concentration of 1-5 µg/ml.

    This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.

    • Target

    • Involvement in diseaseDefects in ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS) [MIM:606693]; also known as Parkinson disease type 9 (PARK9). KRS is a rare hereditary disease with juvenile onset. In addition to typical signs of Parkinson disease, affected individuals show symptoms of more widespread neurodegeneration, including dementia.
    • Sequence similaritiesBelongs to the cation transport ATPase (P-type) (TC 3.A.3) family. Type V subfamily.
    • Cellular localizationMembrane.

      • Target information above from: UniProt accession Q9NQ11 The UniProt Consortium
      The Universal Protein Resource (UniProt) in 2010
      Nucleic Acids Res. 38:D142-D148 (2010) .

      Information by UniProt
    • Database links
      • Alternative names
          AT132_HUMAN antibodyAtp13a2 antibodyATPase type 13A2 antibody
          CLN12 antibodyFLJ26510 antibodyHSA9947 antibodyKRPPD antibodyPARK9 antibodyProbable cation transporting ATPase 13A2 antibodyProbable cation-transporting ATPase 13A2 antibodyPutative ATPase antibodyRP1-37C10.4 antibody
        see all

      Anti-ATP13A2 antibody images

      • Western blot - ATP13A2 antibody (ab57080)
        Western blot - ATP13A2 antibody (ab57080)
        Western blot against tagged recombinant protein immunogen using ab57080 ATP13A2 antibody at 1ug/ml. Predicted band size of immunogen is 36 kDa

      References for Anti-ATP13A2 antibody (ab57080)

      ab57080 has not yet been referenced specifically in any publications.

      Publishing research using ab57080 ? Please let us know so that we can cite the reference in this datasheet

      Product Wall

      Submit an Abreview for ab57080 Submit a Question for ab57080

      Displaying 1 - 1 of 1 results for Abreviews and Q&A

      10
      Votes: Highest First

      Western blot abreview for Anti-ATP13A2 antibody

       Good
      Abreviews
      Application Western blot
      Sample Human Cell lysate - whole cell (HeLa and Fibroblasts)
      Loading amount 40 µg
      Specification HeLa and Fibroblasts
      Gel Running Conditions Reduced Denaturing (4-12% Bis-Tris)
      Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 22°C
      Read More
      abreview image
      Username

      Verified customer

      Submitted Sep 28 2010

      Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"